BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.

Beijing Centergate Technologies (holding) Co., Ltd.

000931

CNE000001030

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
4.45 ^CNY	+0.91%		+1.14%	-24.19%

04-26	Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Beijing Centergate Technologies Co., Ltd. Elects Li Wanjun as Independent Director

August 20, 2018 at 04:32 pm

Beijing Centergate Technologies (holding) Co., Ltd. announced that at its EGM held on August 17, 2018, approved the election of Li Wanjun as an independent director.

Latest news about Beijing Centergate Technologies (holding) Co., Ltd.

Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Centergate Technologies to Build 80 Million Yuan Production Base	03-01	MT
Centergate Technologies Registers Diarrhea Treatment	12-21	MT
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	14/04/22	CI
Beijing Centergate Technologies Co., Ltd. Announces Board Changes	23/02/22	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/08/21	CI
Beijing Centergate Technologies Co., Ltd.(XSEC:000931) dropped from S&P Global BMI Index	21/06/21	CI
Beijing Centergate Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	26/04/21	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	14/04/21	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	26/10/20	CI
Beijing Centergate Technologies Co., Ltd.(XSEC:000931) added to S&P Global BMI Index	21/09/20	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	17/08/20	CI
Gome Holding Group Recommends Beijing Centergate Technologies to Provide Guarantee for Beijing Huasu Pharmaceutical Credit Application	17/04/20	CI
Gome Holding Group Recommends Beijing Centergate Technologies to Provide Liquidity Credit Guarantee for Shandong Hwellso Pharmaceutical	17/04/20	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	14/04/20	CI
Beijing Centergate Technologies Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	28/10/19	CI

Chart Beijing Centergate Technologies (holding) Co., Ltd.

Duration

Period

Chart Beijing Centergate Technologies (holding) Co., Ltd.

More charts

Beijing Centergate Technologies Holding Co Ltd is a China-based company principally engaged in biomedicine, personal care products, elderly care services and other businesses. The Company operates its businesses through four segments. The Biopharmaceutical segment is mainly engaged in the production and sales of external reagents, tablets, injections and other products. The Commercial Concrete segment is mainly engaged in the production and sales of concrete. The Elderly Care and Health segment mainly provides elderly care services. The Other segments mainly provide property management services, sales of existing properties, hotel business and others. The Company mainly operates its businesses in the domestic market, with North China and Northeast China as its main markets.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	-24.19%	463M
ELI LILLY AND COMPANY	+37.74%	723B
NOVO NORDISK A/S	+32.22%	595B
JOHNSON & JOHNSON	-2.07%	369B
MERCK & CO., INC.	+20.25%	332B
ABBVIE INC.	+2.99%	282B
ASTRAZENECA PLC	+16.60%	244B
NOVARTIS AG	+9.77%	208B
ROCHE HOLDING AG	-5.15%	205B
AMGEN INC.	+7.43%	166B